KURA ONCOLOGY, INC. Deferred Tax Assets, Net of Valuation Allowance
KURA ONCOLOGY, INC. (KURA) had Deferred Tax Assets, Net of Valuation Allowance of $1.34 million as of 2022-12-31, per its 10-K filed 2023-02-23.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets › Deferred Tax Assets, Net of Valuation Allowance
us-gaap:DeferredTaxAssetsNet · last filed 2023-02-23
- 2022-12-31: Deferred Tax Assets, Net of Valuation Allowance $1.34M.
- 2021-12-31: Deferred Tax Assets, Net of Valuation Allowance $1.87M.
- 2020-12-31: Deferred Tax Assets, Net of Valuation Allowance $2.12M.
- 2019-12-31: Deferred Tax Assets, Net of Valuation Allowance $165.00K; Deferred Tax Assets, Net of Valuation Allowance as first filed $0.00.
| Period end | Deferred Tax Assets, Net of Valuation Allowance | Deferred Tax Assets, Net of Valuation Allowance as first filed |
|---|---|---|
| 2022-12-31 | $1.34M 10-K · filed 2023-02-23 | |
| 2021-12-31 | $1.87M 10-K · filed 2023-02-23 | |
| 2020-12-31 | $2.12M 10-K · filed 2022-02-24 | |
| 2019-12-31 | $165.00K 10-K · filed 2021-02-24 | $0.00 10-K · filed 2020-02-25 |
| 2018-12-31 | $0.00 10-K · filed 2020-02-25 | |
| 2017-12-31 | $0.00 10-K · filed 2019-03-05 | |
| 2016-12-31 | $0.00 10-K · filed 2018-03-12 | |
| 2015-12-31 | $0.00 10-K · filed 2017-03-14 | |
| 2014-12-31 | $0.00 10-K · filed 2016-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 |